These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 31247102)

  • 1. Germline genetic landscape of pediatric central nervous system tumors.
    Muskens IS; Zhang C; de Smith AJ; Biegel JA; Walsh KM; Wiemels JL
    Neuro Oncol; 2019 Nov; 21(11):1376-1388. PubMed ID: 31247102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of Genomic Sequencing in Pediatric CNS Tumors.
    Bavle AA; Lin FY; Parsons DW
    Oncology (Williston Park); 2016 May; 30(5):411-23. PubMed ID: 27188671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline Variants in Cancer Predisposition Genes in Pediatric Patients with Central Nervous System Tumors.
    Jovanović A; Tošić N; Marjanović I; Komazec J; Zukić B; Nikitović M; Ilić R; Grujičić D; Janić D; Pavlović S
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic predisposition to central nervous system tumors in children - what the neurosurgeon should know.
    Foss-Skiftesvik J; Stoltze UK
    Acta Neurochir (Wien); 2022 Nov; 164(11):3025-3034. PubMed ID: 35660974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hereditary predisposition to tumors of the central and peripheral nervous systems].
    Sourty B; Rousseau A
    Ann Pathol; 2020 Apr; 40(2):168-179. PubMed ID: 32192808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syndromes predisposing to pediatric central nervous system tumors: lessons learned and new promises.
    Villani A; Malkin D; Tabori U
    Curr Neurol Neurosci Rep; 2012 Apr; 12(2):153-64. PubMed ID: 22205236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic and germline genomics in paediatric acute lymphoblastic leukaemia.
    Pui CH; Nichols KE; Yang JJ
    Nat Rev Clin Oncol; 2019 Apr; 16(4):227-240. PubMed ID: 30546053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Sequencing of Malignant Supratentorial Pediatric Brain Tumors Demonstrates a High Frequency of Clinically Relevant Mutations.
    Cole BL; Pritchard CC; Anderson M; Leary SE
    Pediatr Dev Pathol; 2018; 21(4):380-388. PubMed ID: 29173061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor DNA profiling for childhood brain tumors: Technical challenges and evidence for utility.
    Liu AP; Northcott PA; Robinson GW; Gajjar A
    Lab Invest; 2022 Feb; 102(2):134-142. PubMed ID: 34934181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature.
    Sylvester DE; Chen Y; Jamieson RV; Dalla-Pozza L; Byrne JA
    J Med Genet; 2018 Dec; 55(12):785-793. PubMed ID: 30287599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on Cancer Predisposition Syndromes and Surveillance Guidelines for Childhood Brain Tumors.
    Hansford JR; Das A; McGee RB; Nakano Y; Brzezinski J; Scollon SR; Rednam SP; Schienda J; Michaeli O; Kim SY; Greer MC; Weksberg R; Stewart DR; Foulkes WD; Tabori U; Pajtler KW; Pfister SM; Brodeur GM; Kamihara J
    Clin Cancer Res; 2024 Jun; 30(11):2342-2350. PubMed ID: 38573059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of recently described genetic alterations in central nervous system tumors.
    Lucas CG; Solomon DA; Perry A
    Hum Pathol; 2020 Feb; 96():56-66. PubMed ID: 31678207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central Nervous System-type Neuroepithelial Tumors and Tumor-like Proliferations Developing in the Gynecologic Tract and Pelvis: Clinicopathologic Analysis of 23 Cases.
    Murdock T; Orr B; Allen S; Ibrahim J; Sharma R; Ronnett BM; Rodriguez FJ
    Am J Surg Pathol; 2018 Nov; 42(11):1429-1444. PubMed ID: 30074494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
    van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
    J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic predisposition and evolutionary traces of pediatric cancer risk: a prospective 5-year population-based genome sequencing study of children with CNS tumors.
    Stoltze UK; Foss-Skiftesvik J; van Overeem Hansen T; Byrjalsen A; Sehested A; Scheie D; Stamm Mikkelsen T; Rasmussen S; Bak M; Okkels H; Thude Callesen M; Skjøth-Rasmussen J; Gerdes AM; Schmiegelow K; Mathiasen R; Wadt K
    Neuro Oncol; 2023 Apr; 25(4):761-773. PubMed ID: 35902210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic management of neuro-oncologic patients - potential relevance of CSF liquid biopsy.
    von Baumgarten L; Kumbrink J; Jung A; Reischer A; Flach M; Liebmann S; Metzeler KH; Holch JW; Niyazi M; Thon N; Straube A; von Bergwelt-Baildon M; Heinemann V; Kirchner T; Westphalen CB
    Theranostics; 2020; 10(2):856-866. PubMed ID: 31903155
    [No Abstract]   [Full Text] [Related]  

  • 17. Pediatric cancer genetics.
    Dean SJ; Farmer M
    Curr Opin Pediatr; 2017 Dec; 29(6):629-633. PubMed ID: 28984800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact.
    Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association study across pediatric central nervous system tumors implicates shared predisposition and points to 1q25.2 (PAPPA2) and 11p12 (LRRC4C) as novel candidate susceptibility loci.
    Foss-Skiftesvik J; Hagen CM; Mathiasen R; Adamsen D; Bækvad-Hansen M; Børglum AD; Nordentoft M; Werge T; Christiansen M; Schmiegelow K; Juhler M; Mortensen PB; Hougaard DM; Bybjerg-Grauholm J
    Childs Nerv Syst; 2021 Mar; 37(3):819-830. PubMed ID: 33226468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of genomic alterations in primary central nervous system lymphomas.
    Zorofchian S; El-Achi H; Yan Y; Esquenazi Y; Ballester LY
    J Neurooncol; 2018 Dec; 140(3):509-517. PubMed ID: 30171453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.